An in-depth discussion on lenacapavir, this session will examine its potential to transform HIV prevention on a global scale, looking at the latest clinical evidence, regulatory pathways, and the access barriers that may shape its rollout, especially in low-resource settings. The program will feature a special keynote address followed by a panel discussion with leading experts in HIV prevention and global health, exploring how innovation, policy, and equity intersect in the next frontier of HIV response.
Keynote Session
- Moupali Das, MD, MPH, Gilead Sciences
- Keynote Moderator: Dr. Charles B. Holmes, Director, Georgetown University Center for Innovation in Global Health; Distinguished Scholar and Program Director·O’Neill Institute for National and Global Health Law at Georgetown University Law Center
Panel Discussion
- Moderator: Martha Sichone Cameron, PhD Candidate, Global Infectious Disease, Georgetown University
- Micheal Ighodaro, Executive Director, Global Black Gay Men Connect (GBGMC)
- Rupa Patel, MD, MPH, Clinical Researcher, Whitman Walker Institute
- Mitchell Warren, Executive Director, AVAC
